Yeast baker’s

Although a tremendous number of fermentation processes have been researched and developed to various extents, only a couple of hundred ate used commercially. Fermentation industries have continued to expand in terms of the number of new products on the market, the total volume (capacity), and the total sales value of the products. The early 1990s U.S. market for fermentation products was estimated to be in the 9-10 x 10 range. The total world market is probably three times that figure, and antibiotics continue to comprise a primary share of the industry. Other principal product categories are enzymes, several organic acids, baker s yeast, ethanol (qv), vitamins (qv), and steroid hormones (qv). 

Modem technology for produciag microbial cells for human food or animal feed emerged ia Germany duriag World War I. Baker s yeast,... 

Yeast. Several yeast species, including Saccharomjces cerevisiae (baker s yeast) and Klujveromjces lactis are good candidates for the production of certain industrial enzymes, although their abiUty to secrete is much inferior to Bacilli 2in.d Yispergilli. The best-known example of K. lactis is used for commercial production of chymosin [9001-98-3]. 

The two oxidoreductase systems most frequentiy used for preparation of chiral synthons include baker s yeast and horse hver alcohol dehydrogenase (HLAD). The use of baker s yeast has been recendy reviewed in great detail (6,163) and therefore will not be coveted here. The emphasis here is on dehydrogenase-catalyzed oxidation and reduction of alcohols, ketones, and keto acid, oxidations at unsaturated carbon, and Bayer-Vidiger oxidations. 

Xia, Z.-X., et al. Three-dimensional structure of flavocy-tochrome bz from baker s yeast at 3.0 A resolution. Proe. Natl. Aead. Sei. USA 84 2629-2633, 1987. 

The produet itself is the mieroorganism, for example Baker s Yeast and veterinary or human biologieal or vaeeines. 

Even more highly selective ketone reductions are earned out with baker s yeast [61, 62] (equations 50 and 51) Chiral dihydronicotinamides give carbonyl reductions of high enantioselectivity [63] (equation 52), and a crown ether containing a chiral 1,4-dihydropyridine moiety is also effective [64] (equation 52). 

Human Chimpanzee Sheep Rattlesnake Carp Garden snail Tobacco hornworm moth Baker s yeast (iso-1) Cauliflower... 

Baker s yeast, pH 7.2, H2O, EtOH, 62-95% yield with sonication. ... 

Asymmetric synthesis of spiroketahc pheromones Is also reported. In which the asymmetric redncdon of carbonyl group Is carried out with baker s yeast fScheme 4.22. ... 

A short enandoselecdve synthesis of f- -f/f,/f -pytenophorin, a naturaUy occurring and-fun-giil 16-membered macrohde dilactone, is prepared from fS -5-nitropentan-2-ol via the Michael addidon and Nef reacdon fScheme 4.23. The choice of base Is important to get the E-alkene in the Michael addidon, for other bases give a rruxture of and Z-alkenes. The reqidslte chiriil fS -5-nitropentan-2-ol Is prepared by enandoselecdve redncdon of 5-nitropentan-2-one v/ith baker s yeast. ... 

Baker s yeast reducdon of y-nitroketones offers the corresponding chiral nitro alcohols, which areusefid bndding blocks for the synthesis of chiral naniral compounds. For example, opdcally acdve 2-subsdnited pyrrolidine can be prepared using the chiral nitro alcohol fEq. 10.751. ... 

Blckerhefei /. baker s yeast, backflhig, a. capable of baking capable of caking. 

Alternative Step D Reduction with a Reductate — Sucrose (1 kg) is dissolved in water (9 liters) in a 20-liter bottle equipped with a gas trap. Baker s yeast Saccharomyces cerevisiae, 1 kg) is made into a paste with water (1 liter) and added to the sucrose solution with stirring. After lively evolution of gas begins (within 1 to 3 hours), 3-morpholino-4-(3-tert-butylamino-2-oxopropoxy)-1,2,5-thiadiazole hydrogen maleate [1.35 mols, prepared by reaction of the 3-morpholino-4-(3-tert-butylamino-2-oxopropoxy)-1,2,5-thiadiazole with an equimolar quantity of maleic acid in tetrahydrofuran]. The mixture is allowed to stand until fermentation subsides, after which the bottle is kept in a 32°C incubator until all fermentation has ended (in approximately 1 to 3 days). The yeast is filtered off with addition of diatomaceous earth and the filtrate is evaporated to dryness to give S-3-mor-pholino-4/3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole, MP 195° to 198°C (as hydrogen maleate), according to U.S. Patent 3,619,370. 

When excess substrate interferes with growth and/or product formation. One example is the production of baker s yeast. It is known that relatively low concentrations of certain sugars repress respiration and this will make the yeast cells switch to fermentative metabolism, even under aerobic conditions. This, of course, has a negative effect on biomass yield. When maximum biomass production is aimed at, fed batch cultures are the best choice, since the concentration of limiting sugar remains low enough to avoid repression of respiration. 

For preparative purposes fermenting baker s yeast (Saccharomyces cerevisiae) is commonly used instead of a purified enzyme preparation. However, isolated pyruvate decarboxylates can also be used30. In this context, the most important substrate is benzaldehyde31 which is converted by n-glucosc fermenting yeast to (7 )-l-hydroxy-l-phenyl-2-propanone. This conversion has gained considerable industrial importance because ( )-l-hydroxy-1-phenyl-2-propanonc is an important precursor for the synthesis of (-)-cphedrin. 

Fermenting baker s yeast also catalyzes the 1,4-addition of a formal trifluoroethanol-d1-synthon to a,/i-unsaturated aldehydes, to give optically active l,l,l-trifluoro-2-hydroxy-5-alka-nones52. Presumably, the mechanism involves oxidation of the alcohol to the corresponding aldehyde followed by an umpolung step with thiamine pyrophosphate and Michael addition to the a,/i-unsaturated aldehyde. For example, l,l,l-trifluoro-2-hydroxy-5-hexanone (yield 26%, ee 93%) is thus obtained from trifluoroethanol and l-bnten-3-one. 

Insulin, interferon Recombinant E. coli Baker s yeast Human therapy... 

Bioprocess plants are an essential part of food, fine chemical and pharmaceutical industries. Use of microorganisms to transform biological materials for production of fermented foods, cheese and chemicals has its antiquity. Bioprocesses have been developed for an enoimous range of commercial products, as listed in Table 1.1. Most of the products originate from relatively cheap raw materials. Production of industrial alcohols and organic solvents is mostly originated from cheap feed stocks. The more expensive and special bioprocesses are in the production of antibiotics, monoclonal antibodies and vaccines. Industrial enzymes and living cells such as baker s yeast and brewer s yeast are also commercial products obtained from bioprocess plants. 

The aim is to produce biomass or a mass of cells such as microbes, yeast and fungi. The commercial production of biomass has been seen in the production of baker s yeast, which is used in the baking industry. Production of single cell protein (SCP) is used as biomass enriched in protein.6 An algae called Spirulina has been used for animal food in some countries. SCP is used as a food source from renewable sources such as whey, cellulose, starch, molasses and a wide range of plant waste. 

---